A meeting of the Board of Directors of Glenmark Pharmaceuticals Ltd will be held on May 29, 2019, to consider and approve the Standalone and Consolidated Audited Financial Results of the Company for the quarter and year ended March 31, 2019 and to consider and recommend dividend, if any, on Equity Shares for the year ended March 31, 2019.
The Company has intimated its Directors and other designated persons regarding the closure of trading window from April 01, 2019 to May 31, 2019 (both days inclusive) for the purpose of approval of Standalone and Consolidated Audited Financial Results for the year ended March 31, 2019.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.604.95 as compared to the previous close of Rs. 591.65. The total number of shares traded during the day was 41293 in over 1011 trades.
The stock hit an intraday high of Rs. 608.9 and intraday low of 581.1. The net turnover during the day was Rs. 24639124.